Levotiroxina

Levothyroxine Sodium, the active ingredient in Levotiroxina, is a thyroid hormone presented as an oral tablet for oral use. It is used to treat hypothyroidism, replace thyroid hormone after thyroidectomy, and manage goiter in patients requiring hormone supplementation.

GNH USA supplies Levotiroxina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levotiroxina is a synthetic thyroid hormone used to restore normal metabolic function in disorders of thyroid hormone deficiency. - Hypothyroidism: normalizes low thyroid hormone levels and alleviates related symptoms. - Post‑thyroidectomy hormone replacement: provides the missing thyroxine after surgical removal of the thyroid gland. - Goiter: reduces gland enlargement by supplying adequate hormone feedback.

Levotiroxina may cause a range of adverse reactions, most of which are dose‑related and reversible upon adjustment.

Common Side Effects: - Headache: mild to moderate intensity. - Palpitations: sensation of rapid or irregular heartbeat. - Tremor: fine shaking of hands or limbs. - Insomnia: difficulty falling or staying asleep. - Weight loss: unintended reduction in body weight. - Gastrointestinal upset: nausea, vomiting, or abdominal discomfort.

Serious or Rare Side Effects: - Cardiac arrhythmia: potentially life‑threatening irregular heart rhythm. - Angina or myocardial ischemia: chest pain due to reduced heart blood flow. - Osteoporosis: decreased bone mineral density with long‑term excess. - Hyperthyroid symptoms: heat intolerance, sweating, anxiety. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Severe muscle weakness: myopathy or rhabdomyolysis.

Before initiating Levotiroxina therapy, consider patient‑specific factors and monitor appropriately. - Cardiovascular disease: assess heart status, especially in elderly patients. - Diabetes mellitus: monitor blood glucose as thyroid hormone can affect glycemic control. - Pregnancy and lactation: use only if clearly needed; discuss risks with a healthcare provider. - Elderly patients: start with lower doses and titrate cautiously. - Drug interactions: review concomitant medications that may alter absorption or effect. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and direct sunlight.

Levotiroxina absorption and activity can be altered by several co‑administered agents.

Major Interactions (Avoid): - Calcium supplements: bind levothyroxine and reduce its absorption. - Iron salts: significantly decrease oral bioavailability when taken together. - Antacids containing aluminum or magnesium: impair absorption if taken within 4 hours. - Cholestyramine or colestipol: sequester the drug and lower systemic exposure. - Sucralfate: forms complexes that limit absorption.

Moderate Interactions (Monitor Closely): - Warfarin: thyroid hormone may enhance anticoagulant effect; monitor INR. - Diabetes medications: levothyroxine can increase insulin requirements. - Antidepressants (SSRIs, TCAs): may require dose adjustments due to metabolic changes. - Estrogen therapy: may increase levothyroxine binding, necessitating dose review.